Budesonide/formoterol via Turbuhaler® versus formoterol via Turbuhaler® in patients with moderate to severe chronic obstructive pulmonary disease: Phase III multinational study results-Reference-Cited by-同舟云学术

Budesonide/formoterol via Turbuhaler® versus formoterol via Turbuhaler® in patients with moderate to severe chronic obstructive pulmonary disease: Phase III multinational study results

Published:2013-06-21 Issue:5 Volume:18 Page:866-873
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

Fukuchi Yoshinosuke¹,Samoro Ronnie²,Fassakhov Rustem³,Taniguchi Hiroyuki⁴,Ekelund Jan⁵,Carlsson Lars-Goran⁵,Ichinose Masakazu⁶

Affiliation:

1. Department of Respiratory Medicine; Juntendo University; Tokyo

2. Healthlink Medical-Surgical-Dental Clinics and Diagnostic Center; Iloilo City; Philippines

3. Institute of Epidemiology and Microbiology; Kazan; Russian Federation

4. Department of Respiratory Medicine and Allergy; Tosei General Hospital; Aichi

5. AstraZeneca R&D; Molndal; Sweden

6. Department of Respiratory Medicine; Tohoku University Graduate School of Medicine; Miyagi; Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.12090/fullpdf

Reference19 articles.

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease http://www.goldcopd.com

2. Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease;Calverley;Eur. Respir. J.,2003

3. Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial;Rennard;Drugs,2009

4. Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study;Sharafkhaneh;Respir. Med.,2012

5. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease;Szafranski;Eur. Respir. J.,2003

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intraclass comparison of inhaled corticosteroids for the risk of pneumonia in chronic obstructive pulmonary airway disorder: a network meta-analysis and meta-regression;International Journal of Clinical Pharmacy;2024-04-25

2. Association of Inhaled Corticosteroids With All-Cause Mortality Risk in Patients With COPD;Chest;2023-01

3. May a different kinetic mode explain the high efficacy/safety profile of inhaled budesonide?;Pulmonary Pharmacology & Therapeutics;2022-12

4. Efficacy of ICS versus Non-ICS Combination Therapy in COPD: A Meta-Analysis of Randomised Controlled Trials;International Journal of Chronic Obstructive Pulmonary Disease;2022-05

5. Inhaled Corticosteroids and the Pneumonia Risk in Patients With Chronic Obstructive Pulmonary Disease: A Meta-analysis of Randomized Controlled Trials;Frontiers in Pharmacology;2021-06-29